The DEA’s final rule on rescheduling hydrocodone combination products (HCPs) into Controlled Substance Schedule II takes effect Oct. 6. To help pharmacists prepare and discuss the coming change with prescribers and patients, NCPA has prepared a summary of the final rule as well as information for prescribers and pharmacists and a letter that pharmacists can personalize and distribute to their patients. All resources are available for download below.